Kidney Functional Clinical Trial
Official title:
GLP-1: Acute Effects on Kidney Function in Healthy Men
The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GLP-1) affects kidney function in healthy young men. The hypothesis is that GLP-1 induces a positive effect on kidney hemodynamics.
| Status | Completed |
| Enrollment | 12 |
| Est. completion date | December 2011 |
| Est. primary completion date | December 2011 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 18 Years to 30 Years |
| Eligibility |
Inclusion Criteria: - Healthy young men Exclusion Criteria: - Any chronic diseases |
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Klinisk Institut, Afd. MEA, Aarhus Sygehus, NBG | Aarhus C |
| Lead Sponsor | Collaborator |
|---|---|
| Jeppe Skov | Novo Nordisk A/S |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Glomerular Filtration Rate | Every 20 minutes for 6 hours | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02437838 -
Optimizing Drug Doses in Critically Ill
|
N/A |